These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 6798900)

  • 21. Comparison of the efficacy and safety of two preseasonal regimens of glutaraldehyde modified, tyrosine-adsorbed parietaria pollen extract over a period of three years in monosensitive patients.
    Negro JM; Wheeler AW; Hernández J; Youlten LJ; Pascual A; García-Sellés FJ; Pagán JA; López-Sánchez JD; Miralles JC; Sarrió F; Milán JM; Contreras LG; Vidal D
    Allergol Immunopathol (Madr); 1999; 27(3):153-64. PubMed ID: 10431101
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Which allergen extract for grass pollen immunotherapy? An in vitro study.
    Marcucci F; Sensi L; Di Cara G; Incorvaia C; Puccinelli P; Scurati S; Frati F
    Immunol Invest; 2010; 39(6):635-44. PubMed ID: 20653430
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Glutarladehyde-pollen-tyrosine hyposensitization. Course control of therapy using RIST and RAST].
    Jarisch R
    Hautarzt; 1977 Apr; 28(4):185-7. PubMed ID: 406220
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Incorrect treatment of patients with allergic disorders].
    Gniazdowski R
    Wiad Lek; 1986 Feb; 39(4):275-82. PubMed ID: 3088844
    [No Abstract]   [Full Text] [Related]  

  • 25. [Short-term immunotherapy--a survey of current studies].
    Rasp G; Klimek L
    Wien Med Wochenschr; 1999; 149(14-15):403-9. PubMed ID: 10584283
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Human IgG antibody responses to grass pollen antigens: effects of immunotherapy and comparison of serum and secretory profiles.
    Deards MJ; Standring R; Moran DM
    Int Arch Allergy Appl Immunol; 1986; 80(3):253-7. PubMed ID: 3087884
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hyposensitization in hay fever with grass pollen extracts: a three-year study comparing a dialysed alum adsorbed extract with allpyral.
    Haahtela T; Wihl JA; Munch E; Vilkka V; Hagelund CH; Watson HK
    Ann Allergy; 1984 May; 52(5):355-62. PubMed ID: 6721260
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Course of hay fever during the pollen season with respect to the effect of specific immunotherapy. II. Cytologic changes and chemotactic activity in nasal lavage].
    Rozniecka M; Kowałski ML; Grzegorczyk J; Wojciechowska B; Sliwińska-Kowalska M; Rozniecki J
    Pneumonol Alergol Pol; 1995; 63(3-4):144-52. PubMed ID: 7647726
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Treatment of hay fever with "Pollinex"].
    Gniazdowski R
    Otolaryngol Pol; 1978; 32(4):435-40. PubMed ID: 101956
    [No Abstract]   [Full Text] [Related]  

  • 30. [Characteristics of hay fever during pollen season with regard to the influence of specific immunotherapy. I. Clinical course and biochemical changes in nasal lavage].
    Rozniecka M; Kowalski M; Grzegorczyk J; Wojciechowska B; Sliwińska-Kowalska M; Rozniecki J
    Pneumonol Alergol Pol; 1995; 63(3-4):135-43. PubMed ID: 7647725
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Allergen immunotherapy and mast cells.
    Bradding P
    Clin Exp Allergy; 1999 Nov; 29(11):1445-8. PubMed ID: 10520069
    [No Abstract]   [Full Text] [Related]  

  • 32. [Immunotherapy with Alergim PG in pollinosis].
    Rodica RJ; Aurora NE
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Bacteriol Virusol Parazitol Epidemiol; 1988; 33(1):29-34. PubMed ID: 3194617
    [No Abstract]   [Full Text] [Related]  

  • 33. Clinical studies of a purified timothy pollen extract. Desensitization therapy with a purified timothy pollen preparation compared to a crude timothy pollen extract. I. Results of tests in vivo.
    Berg T; Nordvall SL; Lanner A
    Int Arch Allergy Appl Immunol; 1980; 63(3):266-74. PubMed ID: 7419290
    [TBL] [Abstract][Full Text] [Related]  

  • 34. SQ-standardised grass tablet sublingual immunotherapy: persistent clinical benefit and progressive immunological changes during three years treatment.
    Durham SR
    Arb Paul Ehrlich Inst Bundesinstitut Impfstoffe Biomed Arzneim Langen Hess; 2009; 96():121-7; discussion 127-31. PubMed ID: 20799452
    [No Abstract]   [Full Text] [Related]  

  • 35. Pollinex Parietaria (Bencard Parietaria), a new allergoid for treatment of patients sensitive to Parietaria pollen.
    Resta O; Carnimeo N; Foschino MP; Taylor I; Wheeler AW; Youlten LJ
    J Investig Allergol Clin Immunol; 1991 Apr; 1(2):129-37. PubMed ID: 1669569
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Comparison of 3 types of immunotherapy for treating grass pollen-induced allergic rhinitis].
    Hébert J; Bédard PM
    Allerg Immunol (Paris); 1986 Sep; 18(7):19-23. PubMed ID: 3453720
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical effects of specific immunotheraphy in children with atopic dermatitis.
    Trofimowicz A; Rzepecka E; Hofman J
    Rocz Akad Med Bialymst; 1995; 40(2):414-22. PubMed ID: 8834626
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hyposensitization therapy of Parietaria-sensitive patients with a tyrosine adsorbed allergoid, Pollinex Parietaria (Bencard Parietaria).
    Bonifazi F; Antonicelli L; Bilò MB; Pucci S; Taylor IH; Wheeler AW; Youlten LJ
    J Investig Allergol Clin Immunol; 1991 Feb; 1(1):37-44. PubMed ID: 1669563
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Pollinosis in children. Their treatment with delayed allergens].
    Bernard R; Maurel P; Raquet J; Richez P
    Pediatrie; 1970 Dec; 25(8):883-6. PubMed ID: 5494354
    [No Abstract]   [Full Text] [Related]  

  • 40. A trial of hyposensitization in 1974/5 in the treatment of hay fever using glutaraldehyde-pollen-tyrosine adsorbate.
    Miller AC
    Clin Allergy; 1976 Nov; 6(6):557-61. PubMed ID: 827394
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.